Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement

Journal of Endocrinological Investigation

Volumn 30, Issue 4, 2007, Pages 306-312

  Resende de Lima Oliveira Brasil, Rosane ^a,d   Vieira Soares, D ^a   Diniz Carneiro Spina, L ^a   Marise Lobo, P ^a   Carvalho da Silva, E Maria ^a   Mansur Aleta, V ^b   Miguens Castelar Pinheiro, M F ^c   Conceicao F L ^a   Vaisman, M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Previlab Medical Services Ltda

^c Lab Dr Sergio Franco Ltda   (Brazil)

^d NONE   (Brazil)

Author keywords

Ambulatory monitoring of blood pressure (AMBP); Blood pressure; Deficiency; Growth hormone; Insulin resistance

Indexed keywords

ANTIHYPERTENSIVE AGENT; DESMOPRESSIN; GLUCOCORTICOID; GLUCOSE; HUMAN GROWTH HORMONE; INSULIN; SOMATOMEDIN C; STEROID; THYROXINE;

ADULT; ARTICLE; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DRUG DOSE TITRATION; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 34347241666     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03346297     Document Type: Article

References (39)

1. Kylin E. Studien ueber das hypertonie-hyperglykamie-hyperikamiesyndrom. Zentralbeatt fuer Innere Medizin 1923, 44: 105-27.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988, 37: 1595-607.
3. Sowers JR, Frohlich ED. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Med Clin North Am 2004, 88: 63-82.
4. Brett SE, Ritter JM, Chowienczyk PJ. Diastolic blood pressure changes during exercise positively correlate with serum cholesterol and insulin resistance. Circulation 2000, 101: 611-5.
5. Phillips RA, Krakoff RL, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S. Relation among left ventricular mass, insulin resistance, and blood pressure in non obese subjects. J Clin Endocrinol Metab 1998, 83: 4284-8.
6. Heise I, Magnusson K, Heinemann L, Sawicki PT. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension 1998, 32: 243-8.
7. Suzuki M, Kimura Y, Tsushima M, Harano Y. Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure. Hypertension 2000, 35: 864-8.
8. Grassi G, Dell' Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004, 22: 2363-9.
9. Shinozaki K, Ayajiki K, Kashiwagi A, Masada M, Okamura T. Malfunction of vascular control in lifestyle-related disease: Mechanisms underlying endothelial dysfunction in the insulin-resistant state. J Pharmacol Sci 2004, 96: 401-5.
10. Conceição FL, Borjensen A, Jorgensen JOL, Christiansen JS. Growth hormone therapy in adults. Frontiers Neuroendocrinology 2001, 22: 213-46.
11. Jorgensen JOL, Pedersen AS, Thuesen J, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989, 1: 1221-5.
12. Cuneo RC, Salomon F, Wiles CM. Histology of skeletal muscle in adults with GH deficiency: comparison with normal muscle and response to GH treatment. Horm Res 1992, 37: 23-8.
13. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) 1992, 37: 387-97.
14. De Boer H, Blok GJ, Van Der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995, 16: 63-86.
15. Cummings DE, Merriam GR. Growth hormone therapy in adults. Annu Rev Med 2003, 54: 513-33.
16. O'Brien E, Atkins N, Staessen S. State of the market. A review of ambulatory blood pressure monitoring devices. Hypertension 1995, 26: 835-42.
17. Amodeo C, Atie CS, Giorgi DM, Mion JR, Lima D, Lima EG. II Consenso Brasileiro para o uso de Monitorização Ambulatorial da Pressão Arterial. J Bras Nefrol 1997, 19: S2-15
18. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostase model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28: 412-9.
19. Amodeo C, Atie CS, Giorgi DM, Mion JR, Lima D, Lima EG. II Consenso Brasileiro para o uso de Monitorização Ambulatorial da Pressão Arterial. J Bras Nefrol 1997, 19: S2-15.
20. Pickering TG. The clinical significance of diurnal blood pressure variations. Circulation 1990, 81: 700-2.
21. Böger RH, Skamira C, Bode-Boger SM, Brabant G, Von Zur Muhlen A, Frolich JC. Nitric oxide mediates the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency: A double-blind, placebo-control study. J Clin Invest 1996, 98: 2706-13.
22. Caidahl K, Eden S, Bengtsson B-A. cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf) 1994, 40: 393-400.
23. Davidson MB, Vidt DG, Hoogwerf BJ, Brotman DJ. Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus. Am J Cardiol 2005, 95: 123-6.
24. Conceição FL, Mansur VAR, Brasil RRLO, Vaisman M. Ambulatory monitoring of blood pressure in growth hormone-deficient adults. Blood Pressure Monit 2002, 7: 89-94.
25. Reaven G M, Lithell H, Landsberg L. Mechanisms of disease: hypertension and associated metabolic anormalities - the role of insulin resistance and sympathoadrenal system. N Engl J Med 1996, 334: 374-81.
26. Beshyah SA, Henderson A, Niththyananthan R. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab 1995, 80: 356-63.
27. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol 1992, 37: 387-97.
28. O'neal DN, Kalfas A, Dunning PL. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-madiated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. J Clin Endocrinol Metab 1994, 79: 975-83.
29. Mcauley KA, Williams SM, Mann JI. Diagnosing insulin resistance in the general population. Diabetes Care 2001, 24: 460-4.
30. Bonora E, Formentini G Calcaterra F, et al. HOMA-estimated insulin resistance is na independent predictor of cardiovascular disease in type 2 diabetic subjects. Diabetes Care 2002, 25: 1135-41.
31. Bratusch-marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metabol 1982, 55: 973-82.
32. Rizza RA, Mandarino LJ, Gerich JE. Effects of growth hormone on insulin action in man. Diabetes 1982, 31: 663-9.
33. Jorgensen JOL. Fasting metabolism in GHD adults before and after GH replacement. International Growth Monitor 2000, 10: 16-8.
34. Fowelin J, Attvall S, Lager I, Bengtsson B-A. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 1993, 42: 1443-7.
35. Christopher M, Hew FL, Oakley M, Rantzau C, Alford F. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. J Clin Endocrinol Metab 1998, 83: 168-81.
36. Gibney J, Wallace JD, Spinks T, et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-defident patients. J Clin Endocrinol Metab 1999, 84: 2596-602.
37. Chrisoulidou A, Beshyah SA, Rutherford O, et al. Effects of 7 years of growth hormone replacement therapy in hipopituitary adults. J Clin Endocrinol Metab 2000, 85: 3762-9.
38. Johannsson G, Martin P, Lonn L, et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 1997, 82: 727-34.
39. Spina LDC, Soares DV, Brasil RRLO, et al. Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement. Growth Horm IGF Res 2004, 14: 45-51.